ANICARE Trademark

Trademark Overview


On Wednesday, July 27, 2022, a trademark application was filed for ANICARE with the United States Patent and Trademark Office. The USPTO has given the ANICARE trademark a serial number of 97523042. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, May 6, 2024. This trademark is owned by CTTQ-Akeso (Shanghai) Biomed. Tech. Co., Ltd.. The ANICARE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; biological preparations for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hemoglobin; medicines for human purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; drugs for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hematogen for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; injectable medicinal solutions for the ...
anicare

General Information


Serial Number97523042
Word MarkANICARE
Filing DateWednesday, July 27, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, May 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; biological preparations for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hemoglobin; medicines for human purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; drugs for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hematogen for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; injectable medicinal solutions for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCTTQ-Akeso (Shanghai) Biomed. Tech. Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBaoshan, Shanghai 201908
CN

Trademark Events


Event DateEvent Description
Saturday, July 30, 2022NEW APPLICATION ENTERED
Friday, January 5, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, August 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 12, 2023ASSIGNED TO EXAMINER
Friday, May 12, 2023SUSPENSION LETTER WRITTEN
Friday, May 12, 2023LETTER OF SUSPENSION E-MAILED
Friday, May 12, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, January 18, 2024SUSPENSION INQUIRY WRITTEN
Thursday, January 18, 2024INQUIRY TO SUSPENSION E-MAILED
Thursday, January 18, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, February 7, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 7, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, February 7, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 7, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 6, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, May 6, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE